Research Article
Association of FMO3 Variants with Blood Pressure in the Atherosclerosis Risk in Communities Study
Table 1
Baseline characteristics of study populations.
| |||||||||||||||||||||||||||||||||||||||||
Data presented as mean±standard deviation or percentage. SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index. Defined as SBP ≥ 140 mmHg, a DBP ≥ 90 mmHg, or antihypertensive medication usage. †Defined as a fasting glucose ≥ 126 mg/dL, non-fasting glucose ≥ 200 mg/dL, or use of antidiabetes mellitus medication. |